Current and historical daily PE Ratio for BioArctic AB (
) from 2022 to May 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. BioArctic AB stock (BRCTF) PE ratio as of May 24 2024 is 0.
More Details
BioArctic AB (BRCTF) PE Ratio (TTM) Chart
BioArctic AB (BRCTF) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 374
- 1
- 2
- 3
- 4
- 5
| BioArctic AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-24 | At Loss | 2024-03-21 | 92.5 |
| 2024-05-23 | At Loss | 2024-03-20 | 92.5 |
| 2024-05-22 | At Loss | 2024-03-19 | 97.7 |
| 2024-05-21 | At Loss | 2024-03-18 | 97.7 |
| 2024-05-20 | At Loss | 2024-03-15 | 97.7 |
| 2024-05-17 | At Loss | 2024-03-14 | 97.7 |
| 2024-05-16 | At Loss | 2024-03-13 | 97.7 |
| 2024-05-15 | At Loss | 2024-03-12 | 97.7 |
| 2024-05-14 | At Loss | 2024-03-11 | 98.7 |
| 2024-05-13 | At Loss | 2024-03-08 | 96.7 |
| 2024-05-10 | At Loss | 2024-03-07 | 89.3 |
| 2024-05-09 | At Loss | 2024-03-06 | 89.3 |
| 2024-05-08 | At Loss | 2024-03-05 | 89.3 |
| 2024-05-07 | At Loss | 2024-03-04 | 89.3 |
| 2024-05-06 | At Loss | 2024-03-01 | 89.3 |
| 2024-05-03 | At Loss | 2024-02-29 | 89.3 |
| 2024-05-02 | At Loss | 2024-02-28 | 88.8 |
| 2024-05-01 | At Loss | 2024-02-27 | 88.8 |
| 2024-04-30 | At Loss | 2024-02-26 | 88.8 |
| 2024-04-29 | At Loss | 2024-02-23 | 89.1 |
| 2024-04-26 | At Loss | 2024-02-22 | 89.1 |
| 2024-04-25 | At Loss | 2024-02-21 | 92.3 |
| 2024-04-24 | At Loss | 2024-02-20 | 92.3 |
| 2024-04-23 | At Loss | 2024-02-16 | 92.3 |
| 2024-04-22 | At Loss | 2024-02-15 | 91.0 |
| 2024-04-19 | At Loss | 2024-02-14 | 80.0 |
| 2024-04-18 | At Loss | 2024-02-13 | 80.0 |
| 2024-04-17 | At Loss | 2024-02-12 | 82.9 |
| 2024-04-16 | At Loss | 2024-02-09 | 85.0 |
| 2024-04-15 | At Loss | 2024-02-08 | 85.0 |
| 2024-04-12 | At Loss | 2024-02-07 | 85.0 |
| 2024-04-11 | At Loss | 2024-02-06 | 84.9 |
| 2024-04-10 | At Loss | 2024-02-05 | 84.9 |
| 2024-04-09 | At Loss | 2024-02-02 | 85.0 |
| 2024-04-08 | At Loss | 2024-02-01 | 91.5 |
| 2024-04-05 | At Loss | 2024-01-31 | 91.5 |
| 2024-04-04 | At Loss | 2024-01-30 | 90.8 |
| 2024-04-03 | At Loss | 2024-01-29 | 90.8 |
| 2024-04-02 | At Loss | 2024-01-26 | 91.2 |
| 2024-04-01 | At Loss | 2024-01-25 | 96.2 |
| 2024-03-28 | At Loss | 2024-01-24 | 96.2 |
| 2024-03-27 | 85.3 | 2024-01-23 | 96.2 |
| 2024-03-26 | 85.3 | 2024-01-22 | 95.3 |
| 2024-03-25 | 85.3 | 2024-01-19 | 104.0 |
| 2024-03-22 | 92.5 | 2024-01-18 | 104.0 |
BioArctic AB (BRCTF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
BioArctic AB
ISIN : SE0010323311
Share Class Description:
BRCTF: Class BCompare
Compare
Traded in other countries / regions
BIOA B.Sweden0RV2.UKBRCTF.USAB9A.Germany IPO Date
2022-11-16Description
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers